Thoracic Lymphadenopathy

Vikas Pathak, MD (Editor)
Riverside Health System, Newport News, Virginia, USA

Series: New Developments in Medical Research
BISAC: MED022090



Volume 10

Issue 1

Volume 2

Volume 3

Special issue: Resilience in breaking the cycle of children’s environmental health disparities
Edited by I Leslie Rubin, Robert J Geller, Abby Mutic, Benjamin A Gitterman, Nathan Mutic, Wayne Garfinkel, Claire D Coles, Kurt Martinuzzi, and Joav Merrick


Digitally watermarked, DRM-free.
Immediate eBook download after purchase.

Product price
Additional options total:
Order total:



Thoracic lymphadenopathy consists of mediastinal and/or hilar lymphadenopathy. Thoracic lymph nodes are anatomically one of the most complex groups of the lymphatic network in the body and describing them could be nerve wracking if there is no proper understanding of the locations, its systemic divisions and its significance in diseased states. Thoracic lymphadenopathy is one of the most common radiological findings seen on the CT scan of thorax. The incidence of these findings have particularly increased in the era of lung cancer screening with low dose CT scan of the chest. The differential diagnosis for mediastinal and hilar lymphadenopathy is broad and spans from being reactive to benign disease to lung cancer or metastatic cancer.

In this book, we have tried to simplify the lymph node stations based on the latest IASLC guidelines, done a very comprehensive review about mediastinal and hilar lymphadenopathy in different disease states and provided the pathway to diagnosis.

This book also gives a detailed account of noninvasive testing including CT chest and PET CTs. This book also discusses in detail the advanced endoscopic and non-endoscopic procedures like EBUS-TBNA, EUS and Mediastinoscopy that we have at our disposal for the diagnosis of thoracic lymphadenopathy. The indications, contraindications, sensitivity and specificity of each procedure is discussed in detail.
(Imprint: Nova Medicine and Health)



Chapter 1. Anatomy of Mediastinal and Hilar Lymph Nodes
(Christopher Walker, DO, and Vikas Pathak, MD, Campbell University School of Osteopathic Medicine, Fayetteville, North Carolina, US, and others)

Chapter 2. Lung Cancer
(Upendra R. Kaphle, MD, Tulane University School of Medicine, New Orleans, Louisiana, US)

Chapter 3. Metastatic Cancers
(Hyun S Kim, MD, Javeryah Safi MD, and Danai Khemasuwan, MD, St. Elizabeth’s Medical Center/Tufts University School of Medicine, Boston, MA, US)

Chapter 4. Lymphoma
(Santosh Nepal, MD, Geisinger Holy Spirit Hospital, Camp Hill, Pennsylvania, US)

Chapter 5. Infectious Diseases
(Fahad Gul, MD, and Abesh Niroula, MD, Albert Einstein Healthcare Network, Philadelphia, Pennsylvania, US, and others)

Chapter 6. Sarcoidosis
(Christina Mutch, DO, and Vikas Pathak, MD, Riverside Regional Medical Center, Newport News, Virginia, US, and others)

Chapter 7. Interstitial and Occupational Lung Diseases
(Darrin Hursey, MD, Michael Shallcross and Vikas Pathak, MD, WakeMed Health and Hospitals, Raleigh, North Carolina, US, and others)

Chapter 8. Miscellaneous Disorders Affecting Thoracic Lymph Nodes
(Samer Taj-Eldin, MD, WakeMed Health and Hospitals, Raleigh, North Carolina, US)

Chapter 9. Role of EBUS/EUS in the Diagnosis of Mediastinal and Hilar Lymphadenopathy
(Raju Bishwakarma Century, MD, and Vikas Pathak, MD, Winchester Medical Center, Winchester, Virginia, US, and others)

Chapter 10. Mediastinoscopy for the Diagnosis of Mediastinal and Hilar Lymphadenopathy
(Mary K. Bryant, MD, and Trevor C. Upham, MD, University of North Carolina School of Medicine, Chapel Hill, North Carolina, US, and others)

About the Editor


You have not viewed any product yet.